Today, we interact more and more with cloud technologies in our everyday lives. It has become natural to be able to access applications when and where we want in different formats and on different devices.
The life science industry is actively seeking to move to the cloud and reap the benefits of a cloud environment for regulated applications. The cloud does, however, change the way that we need to think about how we deploy, qualify and manage our computerized systems and underlying infrastructure.
Michael Zwetkow - VP Operations, Montrium
Paul Fenton - CEO, Montrium
Gabor Fari - Director, Business Development & Strategy Microsoft
This session provides attendees with a good understanding of the value that the Microsoft Cloud can bring to the pharmaceutical industry, the changes in paradigm that the cloud presents and how the industry is adapting to this change. Finally, we explore how we can qualify the Azure cloud against 21 CFR Part 11 and Annex 11 for regulated applications.